Amanote Research
Register
Sign In
Glycoengineered Antibodies Show Promise
Cancer Discovery
- United States
doi 10.1158/2159-8290.cd-nb2013-040
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
March 14, 2013
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
Review: Behavioural Interventions Show the Most Promise for Chronic Fatigue Syndrome
Evidence-based nursing
Fundamentals
Skills
New Antigen Receptor (NARV) Nanobodies: New Promise for Therapeutic Antibodies
Science Documents
Direct Quality Control of Glycoengineered Erythropoietin Variants
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
Mus Musculus Deficient for Secretory Antibodies Show Delayed Growth With an Altered Urinary Metabolome
Molecular Medicine
Molecular Medicine
Genetics
Molecular Biology
Suggesting a Way to Understand the Actual Potential of Anti-Alzheimer’s Disease Drugs That Show Promise in Transgenic Mouse Models
Frontiers in Neurology
Neurology
Antibodies Elicited by the First Non-Viral Prophylactic Cancer Vaccine Show Tumor-Specificity and Immunotherapeutic Potential
Scientific Reports
Multidisciplinary
Vaccines Against Cancer: Despite Setbacks, Attempts to Harness the Patient's Immune System to Fight Tumor Cells Show Promise in Clinical Trials
EMBO Reports
Biochemistry
Genetics
Molecular Biology
Progress and Promise
eLife
Immunology
Molecular Biology
Biochemistry
Microbiology
Neuroscience
Medicine
Genetics
A Promise